November 29, 2012
Novozymes buys Natural Industries Inc. to bolster position in bioagriculture
Press Release
Novozymes expands its position in key high-value markets for sustainable bioagriculture solutions by acquiring Natural Industries Inc.
Novozymes, the world leader in bioinnovation, has signed a definitive agreement to acquire Natural Industries Inc. based in Houston, US. Natural Industries Inc. has annual revenues of US$5 million and is a bioagricultural company.
"I am excited to have the people and technologies of Natural Industries Inc. join our growing BioAg business. Natural Industries Inc. expands Novozymes'' position in the important biocontrol segment and improves our capabilities to grow our business in key US markets on high-value crops like fruits and vegetables," said Thomas Videb？|k, Executive Vice President of Novozymesand head of BioBusiness.
Biological technologies are natural solutions with multiple modes of action. They are used to improve plant health and growth or combat diseases across various broad-acre crops such as corn and soy and high-value crops such as salads, strawberries and nuts.
The biological solutions complement the use of traditional chemicals and pesticides, which have a world market worth US$150 billion. By contrast, the emerging bioagriculture market is estimated to be worth about US$1 billion with an annual growth rate of 10-15%.
The bioagriculture market is driven by farmers wanting to utilise potent biological solutions to improve agricultural productivity and reduce the environmental impact of their operations, explained Videb？|k.
Natural Industries Inc. has a proven portfolio of products, new pipeline opportunities and good market coverage for high-value crops in key regions of the US.